Lantheus Holdings (LNTH)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$100.97-0.01%
Close 2026-09-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · LNTH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 1,556.3 | 1,541.6 | 1,533.9 | 1,296.4 | 935.1 | 425.2 | 339.4 | 347.3 | 343.4 | 331.4 | 301.9 | 293.5 |
| Total Revenues | — | — | — | — | — | — | — | — | 343.4 | 331.4 | 301.9 | 293.5 |
| Cost of Revenues | 620.3 | 599.7 | 545.6 | 586.9 | 353.4 | 237.5 | 200.6 | 172.5 | 168.5 | — | — | — |
| Gross Profit | 936.0 | 942.0 | 988.3 | 709.5 | 581.7 | 187.7 | 138.8 | 174.8 | 174.9 | 162.1 | 137.8 | 135.5 |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | 173.1 | 177.3 | 168.1 | 77.7 | 311.7 | 45.0 | 32.8 | 20.0 | 17.1 | 18.1 | 12.2 | 14.4 |
| Operating Income | 302.3 | 310.8 | 457.0 | 364.6 | 36.2 | (60.8) | (4.2) | 51.7 | 64.5 | 51.9 | 56.6 | 42.5 |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | 19.7 | 19.7 | 20.0 | 7.2 | 7.8 | 9.5 | 13.6 | 17.4 | 18.4 | 26.6 | 38.7 |
| Interest & Investment Income | — | — | 36.8 | 19.6 | 2.6 | 0.0 | 0.2 | 0.7 | — | — | — | 0.0 |
| Net Interest Expenses | — | — | — | 0.4 | 4.6 | 7.7 | 9.2 | 12.9 | — | — | — | 38.7 |
| Asset Writedown | — | — | — | 138.1 | 0.0 | 9.7 | 7.3 | — | — | — | — | — |
| EBT, Incl. Unusual Items | 363.0 | 313.8 | 431.0 | 410.9 | 26.7 | (75.0) | (11.5) | 28.6 | 49.5 | 39.6 | 28.3 | (11.8) |
| Income Tax Expense | 87.7 | 80.2 | 118.5 | 84.3 | (1.3) | (3.8) | 2.0 | (3.0) | 9.0 | (83.7) | 1.5 | 3.0 |
| Net Income | ||||||||||||
| Net Income | 275.3 | 233.6 | 312.4 | 326.7 | 28.1 | (71.3) | (13.5) | 31.7 | 40.5 | 123.4 | 26.8 | (14.7) |
| Per Share | ||||||||||||
| Basic EPS | 4.23 | 3.46 | 4.52 | 4.79 | 0.41 | (1.06) | (0.25) | 0.81 | 1.06 | 3.31 | 0.84 | — |
| Diluted EPS | 4.08 | 3.41 | 4.36 | 4.65 | 0.40 | (1.06) | (0.25) | 0.79 | 1.03 | 3.17 | 0.82 | — |
| Revenue per Share | 23.05 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 65.2 | 67.5 | 69.2 | 68.3 | 68.5 | 67.5 | 54.1 | 39.0 | 38.2 | 37.3 | 32.0 | — |
| Diluted Weighted Avg Shares | 67.5 | 68.4 | 71.7 | 70.2 | 70.7 | 67.5 | 54.1 | 40.1 | 39.5 | 38.9 | 32.7 | — |
| Supplemental | ||||||||||||
| EBITDA | — | 380.9 | 521.6 | 424.7 | 84.1 | (18.5) | 19.1 | 63.7 | 77.3 | 70.0 | 73.9 | 61.4 |
| EBIT | 302.3 | 310.8 | 457.0 | 364.6 | 36.2 | (60.8) | (4.2) | 51.7 | 64.5 | 51.9 | 56.6 | 42.5 |
| Effective Tax Rate | 24.2% | — | — | 20.5% | -5.0% | 5.0% | -17.4% | -10.6% | 18.2% | -211.3% | 5.4% | -25.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.